Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Accounts Payables (2020 - 2026)

Biomea Fusion (BMEA) posted Accounts Payables of $4.6 million for Q1 2026, up 42.68% sequentially from $3.2 million in Q4 2025, and down 40.15% YoY from $7.7 million in Q1 2025.

Biomea Fusion (BMEA) Accounts Payables (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Accounts Payables for 7 years, with the latest figure at $4.6 million in Q1 2026.

  • Quarterly Accounts Payables fell 40.15% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 40.15% YoY) and the FY2025 annual result came in at $3.2 million, down 75.0% from the prior year.
  • Accounts Payables improved to $4.6 million in Q1 2026 per BMEA's latest filing, from $3.2 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $12.9 million in Q4 2024 and troughed at $1.6 million in Q3 2022.
  • A 5-year average of $5.6 million and a median of $5.3 million in 2023 frame the typical range for Accounts Payables.
  • The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 413.62% in 2022, then plunged 75.0% in 2025.
  • Over 5 years, Accounts Payables stood at $6.8 million in 2022, then grew by 0.37% to $6.9 million in 2023, then jumped by 88.76% to $12.9 million in 2024, then slumped by 75.0% to $3.2 million in 2025, then jumped by 42.68% to $4.6 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $4.6 million, $3.2 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 167.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 470.30 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 108.02 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 622.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 428.93 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 35.57 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 3.31 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.31 Mn
Mar 31, 2026 4.61 Mn
Dec 31, 2025 3.23 Mn
Sep 30, 2025 6.40 Mn
Jun 30, 2025 8.38 Mn
Mar 31, 2025 7.71 Mn
Dec 31, 2024 12.93 Mn
Sep 30, 2024 8.99 Mn
Jun 30, 2024 5.83 Mn
Mar 31, 2024 4.71 Mn
Dec 31, 2023 6.85 Mn
Sep 30, 2023 3.19 Mn
Jun 30, 2023 4.15 Mn
Mar 31, 2023 5.33 Mn
Dec 31, 2022 6.83 Mn
Sep 30, 2022 1.59 Mn
Jun 30, 2022 2.41 Mn
Mar 31, 2022 2.52 Mn
Dec 31, 2021 1.33 Mn
Sep 30, 2021 1.25 Mn